Skip to main navigation Skip to search Skip to main content

Correction: Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios (Translational Psychiatry, (2020), 10, 1, (9), 10.1038/s41398-020-0692-2)

  • Lingli Zhang
  • , Chu Chung Huang
  • , Yuan Dai
  • , Qiang Luo
  • , Yiting Ji
  • , Kai Wang
  • , Shining Deng
  • , Juehua Yu
  • , Mingyu Xu
  • , Xiujuan Du
  • , Yun Tang
  • , Chun Shen
  • , Jianfeng Feng
  • , Barbara J. Sahakian
  • , Ching Po Lin
  • , Fei Li*
  • *Corresponding author for this work
  • Shanghai Jiao Tong University
  • Fudan University
  • University of Cambridge
  • National Yang Ming Chiao Tung University

Research output: Contribution to journalComment/debate

Abstract

An important detail was omitted in the Method of the original Article, I.E, The CARS and other evaluations were conducted ‘blind' to condition (Bumetanide or no treatment) by experienced clinicians. This has now been updated in the HTML and PDF versions of this Article.

Original languageEnglish
Article number63
JournalTranslational Psychiatry
Volume10
Issue number1
DOIs
StatePublished - 1 Dec 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction: Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios (Translational Psychiatry, (2020), 10, 1, (9), 10.1038/s41398-020-0692-2)'. Together they form a unique fingerprint.

Cite this